Reimagine what's essential.
Refocus what's attainable.
Rethink what's possible.

As our world continues to change in the midst of the global COVID-19 pandemic, we have a profound opportunity to shift the infectious disease paradigm—and a vital responsibility to lead the charge.

It's time to counter confusion with clarity.

Introducing the Infectious Disease Council.

An international coalition of interdisciplinary experts representing the fields of pandemic infectious disease policy, healthcare, education, medical diagnostics and testing, and law have formed the InfectiousDisease Council to help organizations and individuals strike back against COVID-19.

Work Smart. Work Safe. Work Well.

Masking, Washing and Distancing are still critical while vaccines roll out

Masking, Washing and Distancing are Still Critical While Vaccines Roll Out

The CDC’s emergency use authorization of two COVID-19 vaccines in December 2020 marked a turning point in the pandemic. But that does not mean individuals should stop taking steps to prevent the spread of the virus. The CDC and other health officials recommend that all people, including individuals who have received the COVID-19 vaccine, continue…

Proof of Vaccination as a Passport to Goods and Services: Practice Tips for Businesses and Institutions

In the coming months, COVID-19 immunizations in the United States will extend beyond priority groups to the general population. Businesses, under increasing pressure to draw back clientele who have stayed away during the pandemic, may see requiring their customers to present proof of vaccination as a way to draw customers by guaranteeing a safe environment.…

An Insight from OADN’s CEO during the Pandemic

As the country has been faced with the Coronavirus Disease pandemic (COVID-19), the Organization for Associate Degree Nursing (OADN) has stood steadfast in support of all nurse educators, nurses, and the entire healthcare workforce as they care for the ill and vulnerable. Nurses are resilient, reliable, and proven responders during infectious disease emergencies, providing safe,…

Anticipating COVID-19 Vaccine: What Should Institutions of Higher Education and Employers Do Now?

The U.S. Food and Drug Administration (FDA) has now issued Emergency Use Authorizations (EUAs) for two COVID-19 vaccines, with more in the pipeline. With this encouraging development, employers and institutions of higher education (IHEs) must prepare to grapple with whether they can require employees or students to be immunized as a condition of employment or…
Covid-19 Coronavirus Vaccine vials in a row macro close up

COVID-19 Vaccines: Important Considerations

The WHO declared the spread of the SARS coronavirus-2 (SARS-CoV2) a public health emergency of global concern on January 30th, 2020. Since that time, the world has registered nearly than 57 million infections, with deaths surpassing 1.3 million[1]. Since this respiratory virus spreads from person to person through close contact, and without a vaccine or…
Corona virus and research

Benefits and Challenges of COVID-19 Vaccination

There has been very good news reported recently from ongoing Phase 3 COVID-19 vaccine trials. Two so–called mRNA vaccines COVID-19 vaccines have shown very high efficacies including one produced by Pfizer and another by Moderna. Pfizer reported an efficacy of 94.5% and Moderna 95%. Efficacy is measured by calculating the risk of a disease among…